Re-evaluation of response criteria in chronic
lymphocytic leukemia and the significance of minimal residual
disease
Michael Hallek
Evaluation of minimal residual disease in
chronic lymphocytic leukemia
Matthias Ritgen, Sebastian Böttcher, Peter Dreger, Michael
Kneba
Elimination of minimal residual disease in
chronic lymphocytic leukemia using allogeneic stem cell
transplantation
Matthias Ritgen, Stephan Stilgenbauer, Andreas Humpe, Norbert
Schmitz, Hartmut Döhner, Michael Kneba, Peter Dreger
Minimal residual disease elimination by
consolidation therapy with alemtuzumab
Susan O’Brien
Minimal residual disease following
chemoimmunotherapy for patients with relapsed chronic lymphocytic
leukemia
Andreas Engert, Holger Schultz, Thomas Elter
The role of minimal residual disease
elimination in the outcome of chronic lymphocytic
leukemia
Michael Hallek